CD38, ZAP-70 and the IGHV gene are typical immunophenotypic and genetic prognostic markers (11,12), which have previously been used to predict the survival of CLL patients in the clinic. The gene discussed is CD38; the disease is B-cell chronic lymphocytic leukemia.